Remicade (infliximab) - J&J
Humira (adalimumab) - AbbVie
tofacitinib - Generic mfg.
Stelara (ustekinumab) - J&J
Jyseleca (filgotinib) - Gilead
Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim
Simponi (golimumab) - J&J
Rinvoq (upadacitinib) - AbbVie
Entyvio (vedolizumab) - Takeda
Zeposia (ozanimod) - BMS
https://acg2026.eventscribe.net/ajaxcalls/PosterInfo.asp?efp=R01PT1FGR0UyNjkyNQ&PosterID=830145&rnd=0.1177622
 
Joana Torres MD 1; Mark Samaan MD 2; Brigid Boland MD 3; Gil Y. Melmed MD MS FACG 4; Colla Cunneen MD 5; Daniel O'Brien PhD 5; Jasmina Kalabic MD 6; Nurbek Mambetsariev MD 7; Xiao Li PhD 7; Marc Ferrante MD 8
 
Aug 29, 2026
 
Prev Next